Revvity SG&A Expenses 2010-2025 | RVTY
Revvity annual/quarterly sg&a expenses history and growth rate from 2010 to 2025. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
- Revvity sg&a expenses for the quarter ending March 31, 2025 were $0.250B, a 4.16% decline year-over-year.
- Revvity sg&a expenses for the twelve months ending March 31, 2025 were $0.983B, a 4.96% decline year-over-year.
- Revvity annual sg&a expenses for 2024 were $0.994B, a 2.78% decline from 2023.
- Revvity annual sg&a expenses for 2023 were $1.023B, a 0.29% decline from 2022.
- Revvity annual sg&a expenses for 2022 were $1.026B, a 5.16% increase from 2021.
| Revvity Annual SG&A Expenses (Millions of US $) |
|
|---|---|
| 2024 | $994 |
| 2023 | $1,023 |
| 2022 | $1,026 |
| 2021 | $975 |
| 2020 | $716 |
| 2019 | $815 |
| 2018 | $812 |
| 2017 | $626 |
| 2016 | $590 |
| 2015 | $587 |
| 2014 | $648 |
| 2013 | $582 |
| 2012 | $627 |
| 2011 | $624 |
| 2010 | $487 |
| 2009 | $477 |
| Revvity Quarterly SG&A Expenses (Millions of US $) |
|
|---|---|
| 2025-03-31 | $250 |
| 2024-12-31 | $244 |
| 2024-09-30 | $238 |
| 2024-06-30 | $252 |
| 2024-03-31 | $261 |
| 2023-12-31 | $257 |
| 2023-09-30 | $250 |
| 2023-06-30 | $267 |
| 2023-03-31 | $249 |
| 2022-12-31 | $244 |
| 2022-09-30 | $243 |
| 2022-06-30 | $263 |
| 2022-03-31 | $275 |
| 2021-12-31 | $166 |
| 2021-09-30 | $276 |
| 2021-06-30 | $282 |
| 2021-03-31 | $251 |
| 2020-12-31 | $62 |
| 2020-09-30 | $225 |
| 2020-06-30 | $221 |
| 2020-03-31 | $209 |
| 2019-12-31 | $211 |
| 2019-09-30 | $204 |
| 2019-06-30 | $202 |
| 2019-03-31 | $199 |
| 2018-12-31 | $211 |
| 2018-09-30 | $197 |
| 2018-06-30 | $205 |
| 2018-03-31 | $200 |
| 2017-12-31 | $176 |
| 2017-09-30 | $153 |
| 2017-06-30 | $150 |
| 2017-03-31 | $147 |
| 2016-12-31 | $152 |
| 2016-09-30 | $143 |
| 2016-06-30 | $151 |
| 2016-03-31 | $145 |
| 2015-12-31 | $147 |
| 2015-09-30 | $148 |
| 2015-06-30 | $147 |
| 2015-03-31 | $146 |
| 2014-12-31 | $206 |
| 2014-09-30 | $143 |
| 2014-06-30 | $147 |
| 2014-03-31 | $152 |
| 2013-12-31 | $140 |
| 2013-09-30 | $143 |
| 2013-06-30 | $148 |
| 2013-03-31 | $151 |
| 2012-12-31 | $175 |
| 2012-09-30 | $145 |
| 2012-06-30 | $150 |
| 2012-03-31 | $157 |
| 2011-12-31 | $220 |
| 2011-09-30 | $133 |
| 2011-06-30 | $138 |
| 2011-03-31 | $133 |
| 2010-12-31 | $122 |
| 2010-09-30 | $121 |
| 2010-06-30 | $123 |
| 2010-03-31 | $122 |
| 2009-12-31 | $111 |
| 2009-09-30 | $113 |
| 2009-06-30 | $124 |
| 2009-03-31 | $129 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $12.019B | $2.755B |
| Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $145.222B | 26.93 |
| CVS Health (CVS) | United States | $74.320B | 9.24 |
| Elevance Health (ELV) | United States | $63.147B | 8.49 |
| Cencora (COR) | United States | $56.296B | 19.58 |
| DiDi Global (DIDIY) | China | $26.168B | 27.80 |
| Labcorp Holdings (LH) | United States | $22.406B | 17.68 |
| Natera (NTRA) | United States | $19.262B | 0.00 |
| BioMerieux (BMXMF) | France | $15.985B | 0.00 |
| ICON (ICLR) | Ireland | $15.748B | 15.15 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.835B | 0.00 |
| CochLear (CHEOY) | Australia | $13.402B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.801B | 33.88 |
| Solventum (SOLV) | United States | $12.791B | 13.54 |
| Viatris (VTRS) | United States | $10.974B | 3.77 |
| Avantor (AVTR) | United States | $9.547B | 13.87 |
| Sonic Healthcare (SKHHY) | Australia | $9.287B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.698B | 17.05 |
| HealthEquity (HQY) | United States | $8.162B | 35.75 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.502B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.943B | 29.10 |
| BrightSpring Health Services (BTSG) | United States | $3.632B | 33.32 |
| Sotera Health (SHC) | United States | $3.437B | 19.53 |
| Surgery Partners (SGRY) | United States | $2.693B | 35.02 |
| Organon (OGN) | United States | $2.618B | 2.78 |
| Concentras Parent (CON) | United States | $2.517B | 14.55 |
| GeneDx Holdings (WGS) | United States | $2.324B | 89.50 |
| Alignment Healthcare (ALHC) | United States | $2.303B | 0.00 |
| Progyny (PGNY) | United States | $1.972B | 43.40 |
| GoodRx Holdings (GDRX) | United States | $1.775B | 35.50 |
| Premier (PINC) | United States | $1.747B | 13.26 |
| PACS (PACS) | United States | $1.742B | 0.00 |
| Ardent Health (ARDT) | United States | $1.543B | 6.58 |
| Teladoc Health (TDOC) | United States | $1.439B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.248B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.067B | 8.12 |
| QDM (QDMI) | Hong Kong, SAR China | $0.997B | 342.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.857B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.750B | 7.03 |
| CareDx (CDNA) | United States | $0.715B | 11.16 |
| Embecta (EMBC) | United States | $0.665B | 4.48 |
| Nutex Health (NUTX) | United States | $0.532B | 8.05 |
| InnovAge Holding (INNV) | United States | $0.513B | 0.00 |
| SBC Medicals (SBC) | United States | $0.505B | 0.00 |
| Omada Health (OMDA) | $0.486B | 0.00 | |
| LifeMD (LFMD) | United States | $0.485B | 0.00 |
| So-Young (SY) | China | $0.480B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.469B | 10.55 |
| Sonida Senior Living (SNDA) | United States | $0.463B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.409B | 0.00 |
| Enhabit (EHAB) | United States | $0.349B | 28.71 |
| Oncology Institute (TOI) | United States | $0.326B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.287B | 0.00 |
| Beauty Health (SKIN) | United States | $0.231B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.187B | 0.00 |
| DocGo (DCGO) | United States | $0.148B | 24.17 |
| Sera Prognostics (SERA) | United States | $0.122B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.083B | 0.00 |
| KindlyMD (NAKA) | United States | $0.080B | 0.00 |
| Biodesix (BDSX) | United States | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.041B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |